Skip to main content

Full Schedule

Full Schedule

  • Monday, October 14, 2024
  • 8:00 AM – 5:00 PM PT
    (1) Residency Program Design and Conduct
  • 1:00 PM – 4:00 PM PT
    (2) Hot Topics in Health Policy: Focus on Medicare Part D Redesign and PBM Reform
  • Tuesday, October 15, 2024
  • 8:30 AM – 9:45 AM PT
    (3) Identifying the Managed Care Impact of Bipolar Disorder: Treatment Advancements, Accurate Diagnosis, and Equitable Care
  • 8:30 AM – 9:45 AM PT
    (4) Federal Legislative and Regulatory Update
  • 8:30 AM – 9:45 AM PT
    (5) What You Need to Know About Copay Accumulators, Maximizers, and Alternative Funding Programs
  • 8:30 AM – 9:45 AM PT
    (6) AI in Healthcare: From Cutting-Edge Innovations to Practical Applications in Formulary Decision Making
  • 8:30 AM – 9:45 AM PT
    (7) A beginner's guide to decoding cell and gene therapy
  • 10:15 AM – 11:30 AM PT
    (8) “Pound for Pound” Assessment of Anti-Obesity Medications, Coverage Policies, and Financial Considerations
  • 10:15 AM – 11:30 AM PT
    (9) Executive to Executive: Leading Managed Care Organizations Today
  • 10:15 AM – 11:30 AM PT
    (10) Improving Quality Measure Performance: Real-World Insights from a Pharmacist-Led, Collaborative, Clinical Program
  • 10:15 AM – 11:30 AM PT
    (12) Gene Therapy in Sickle Cell Disease – Breakthroughs in Treatment and Coverage
  • 10:15 AM – 11:45 AM PT
    (11) Unlocking the Power of Precision Medicine: Biomarker-Driven Oncology Care
  • 3:30 PM – 4:45 PM PT
    (13) Rare Disease Spotlight: Transthyretin Amyloidosis Cardiomyopathy (ATTR‐CM) Disease Burden, Unmet Needs, and Treatment Advances
  • 3:30 PM – 4:45 PM PT
    (14) Navigating Uncertainty: Best Practices in Balancing Actuarial Pricing and Formulary Management
  • 3:30 PM – 4:45 PM PT
    (15) Navigating Health Disparities: A Case Study Approach
  • 3:30 PM – 4:45 PM PT
    (16) Research Podium Session – Leveraging Real-World Data to Advance Managed Care Pharmacy Practice
  • 3:35 PM – 4:45 PM PT
    (17) Are Patients Getting a Fair Share of the Value of Biosimilars?
  • Wednesday, October 16, 2024
  • 8:30 AM – 9:45 AM PT
    (18) Specialty Pharmaceuticals in Development
  • 10:15 AM – 11:15 AM PT
    (21) State Legislative and Regulatory Update
  • 10:15 AM – 11:30 AM PT
    (20) WIN-WIN: Negotiate Your Career with Confidence
  • 10:15 AM – 11:30 AM PT
    (22) Insights into Retinal Health: Bridging Payer Gaps for Timely and Equitable Care
  • 10:15 AM – 11:30 AM PT
    (23) Advancing Patient Care and Demonstrating Value in Specialty Pharmacy Using Technology and Data-Driven Quality Improvement Solutions
  • 10:30 AM – 11:45 AM PT
    (19) Maximizing Utilization and Continuity of Care: Advancing Adalimumab Biosimilar Adoption in Managed Care
  • 2:30 PM – 3:45 PM PT
    (24) Advancing Schizophrenia Management Strategies in the Patient Journey: Treatment Innovations, Adherence, and Health Outcomes
  • 2:30 PM – 3:45 PM PT
    (25) Current Patterns, Future Shifts, and Best Practices in U.S. Specialty Drug Coverage
  • 2:30 PM – 3:45 PM PT
    (26) Bridging the Gap: Development of Real-World Evidence (RWE) Standards to Facilitate Communication Between Manufacturers and Payers through the AMCP RWE Initiative
  • 2:30 PM – 3:45 PM PT
    (27) Pharmacoeconomics & Formulary Management Student Workshop
  • 4:00 PM – 5:15 PM PT
    (28) Navigating the Final Chapter: What’s Next for Your Managed Care Pharmacy Career Journey- Opportunity for Rewirement vs Retirement
  • 4:00 PM – 5:15 PM PT
    (29) CY 2025 Part D Redesign: A Medicare Odyssey
  • 4:00 PM – 5:15 PM PT
    (30) GLP-1 Agonists for Weight Management within the Commercially Insured Market: How Real-world Evidence Can Inform Benefit Design
  • Thursday, October 17, 2024
  • 9:00 AM – 10:15 AM PT
    (31) The 2024 Election and Its Impact on Health Policy
  • 10:30 AM – 11:45 AM PT
    (32) Oncology Pipeline 2024: Innovation and Trends